EXIT Bio

EXIT Bio is a Frederick-based biotech company developing advanced 3D tissue models that accelerate therapeutic discovery and improve clinical relevance. Using patient-derived cells and human extracellular matrix (ECM), their novel platform recreates realistic tumor microenvironments for rapid, high content drug screening. These all-human models generate more predictive data than traditional systems, helping researchers and industry partners bridge the gap between preclinical testing and patient outcomes.